ARTICLE | Company News
ADImmune Corp., Crucell deal
March 26, 2007 7:00 AM UTC
ADImmune received an exclusive license to use CRXL's virosome technology to produce a virosomal adjuvanted influenza vaccine in Taiwan, Japan and Macau. ADImmune also will produce influenza antigen, ...